BillionToOne BLLN
NASDAQ BLLN
$95.29 -0.93 (-0.97%)
As of: Aug 27, 2026 · 3:59 PM EDT

BillionToOne (BLLN) Other Non-Current Liabilities (2024 - 2025)

BillionToOne (BLLN) posted Other Non-Current Liabilities of $4.3 million for Q3 2025, up 57.37% sequentially from $2.8 million in Q4 2024.

BillionToOne (BLLN) Other Non-Current Liabilities (2024 - 2025) Analysis & Trends

BillionToOne has reported Other Non-Current Liabilities for 2 years, with the latest figure at $4.3 million in Q3 2025.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $4.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.3 million (changed N/A YoY) and the FY2024 annual result came in at $2.8 million, changed N/A from the prior year.
  • Other Non-Current Liabilities improved to $4.3 million in Q3 2025 per BLLN's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $4.3 million in Q3 2025 and troughed at $2.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 BillionToOne 4.42 Bn 3.87 Bn 77.11 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 4.35 Mn
Dec 31, 2024 2.76 Mn